Clinical trials start faster in Asia-Pacific than in the West. Here’s why.

 by Cindy Venendaal

The number of clinical trials conducted in the Asia-Pacific Rim is increasing, rising from 6% of the global total in 2005/2007 to 10% in 2011. (Clinical Trial Magnifier 2011, One of the key factors driving growth is faster study start-up times compared with the West. Much of this timeline compression can be attributed to two issues: patient recruitment and regulatory approvals.

Patient Recruitment

With over 60% of the world’s population living in Asia, (PriceWaterhouseCoopers 2009, one of the main reasons that trials enroll quickly is the sheer number of available patients. However, there are several other important factors that should not be overlooked. Read More